Fig. 4From: Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosisThis forest plot shows that the difference in the primary clinical outcome (common odds ratio indicating the odds of improvement of 0–1 point on the modified Rankin Scale at 90 days, analyzed with the use of ordinal logistic regression) favored the argatroban group across all prespecified subgroupsBack to article page